Showing results (1-10 of 392) with videos related to

Sort By:
Pageof 40
Frontiers in Medicine|December 23, 2022
Prostate specific membrane antigen binding radiopharmaceuticals: Current data and new conceptsOliver Sartor, Ali Baghian
Nature Reviews. Urology|September 7, 2010
Prostate cancer. Saturation biopsy does not accurately localize tumorsOliver Sartor
The Oncologist|October 26, 2018
Conflicts of Interest, Baselga, and Clinical TrialistsOliver Sartor
Asia-Pacific Journal of Clinical Oncology|November 30, 2018
Advanced prostate cancer update 2018Oliver Sartor
The Journal of the Louisiana State Medical Society : Official Organ of the Louisiana State Medical Society|August 7, 2008
Prostate specific antigen (PSA) may be a poor marker for progression of prostate cancer after treatment with a combination of chemo-hormonal therapiesOliver Sartor
Nature Reviews. Clinical Oncology|August 3, 2011
Combination therapy: Abiraterone prolongs survival in metastatic prostate cancerOliver Sartor
Cancer Journal (Sudbury, Mass.)|October 18, 2016
Isotope Therapy for Castrate-Resistant Prostate Cancer: Unique Sequencing and CombinationsOliver Sartor
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 2023
Circulating Tumor DNA Biomarkers for Response Assessment in Prostate CancerOliver Sartor
Asian Journal of Andrology|September 11, 2012
Implications of the prostate intervention versus observation trial (PIVOT)Oliver Sartor
Pageof 40